These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Intracellular amyloid-β accumulation in calcium-binding protein-deficient neurons leads to amyloid-β plaque formation in animal model of Alzheimer's disease. Moon M; Hong HS; Nam DW; Baik SH; Song H; Kook SY; Kim YS; Lee J; Mook-Jung I J Alzheimers Dis; 2012; 29(3):615-28. PubMed ID: 22269161 [TBL] [Abstract][Full Text] [Related]
5. Mechanism of neuronal versus endothelial cell uptake of Alzheimer's disease amyloid beta protein. Kandimalla KK; Scott OG; Fulzele S; Davidson MW; Poduslo JF PLoS One; 2009; 4(2):e4627. PubMed ID: 19247480 [TBL] [Abstract][Full Text] [Related]
6. Drastic neuronal loss in vivo by beta-amyloid racemized at Ser(26) residue: conversion of non-toxic [D-Ser(26)]beta-amyloid 1-40 to toxic and proteinase-resistant fragments. Kaneko I; Morimoto K; Kubo T Neuroscience; 2001; 104(4):1003-11. PubMed ID: 11457586 [TBL] [Abstract][Full Text] [Related]
7. Perlecan Domain V Inhibits Amyloid-β Induced Activation of the α2β1 Integrin-Mediated Neurotoxic Signaling Cascade. Parham CL; Shaw C; Auckland LD; Dickeson SK; Griswold-Prenner I; Bix G J Alzheimers Dis; 2016 Oct; 54(4):1629-1647. PubMed ID: 27636841 [TBL] [Abstract][Full Text] [Related]
8. In vivo assessment of brain interstitial fluid with microdialysis reveals plaque-associated changes in amyloid-beta metabolism and half-life. Cirrito JR; May PC; O'Dell MA; Taylor JW; Parsadanian M; Cramer JW; Audia JE; Nissen JS; Bales KR; Paul SM; DeMattos RB; Holtzman DM J Neurosci; 2003 Oct; 23(26):8844-53. PubMed ID: 14523085 [TBL] [Abstract][Full Text] [Related]
9. Impacts of aging and amyloid-β deposition on plasminogen activators and plasminogen activator inhibitor-1 in the Tg2576 mouse model of Alzheimer's disease. Bi Oh S; Suh N; Kim I; Lee JY Brain Res; 2015 Feb; 1597():159-67. PubMed ID: 25454795 [TBL] [Abstract][Full Text] [Related]
10. Correlation between orphan nuclear receptor Nurr1 expression and amyloid deposition in 5XFAD mice, an animal model of Alzheimer's disease. Moon M; Jeong I; Kim CH; Kim J; Lee PK; Mook-Jung I; Leblanc P; Kim KS J Neurochem; 2015 Jan; 132(2):254-62. PubMed ID: 25156412 [TBL] [Abstract][Full Text] [Related]
11. Critical role of soluble amyloid-β for early hippocampal hyperactivity in a mouse model of Alzheimer's disease. Busche MA; Chen X; Henning HA; Reichwald J; Staufenbiel M; Sakmann B; Konnerth A Proc Natl Acad Sci U S A; 2012 May; 109(22):8740-5. PubMed ID: 22592800 [TBL] [Abstract][Full Text] [Related]
12. Differential Effects of Alzheimer's Disease Aβ40 and 42 on Endocytosis and Intraneuronal Trafficking. Omtri RS; Thompson KJ; Tang X; Gali CC; Panzenboeck U; Davidson MW; Kalari KR; Kandimalla KK Neuroscience; 2018 Mar; 373():159-168. PubMed ID: 29337241 [TBL] [Abstract][Full Text] [Related]
13. Plaque formation and the intraneuronal accumulation of β-amyloid in Alzheimer's disease. Takahashi RH; Nagao T; Gouras GK Pathol Int; 2017 Apr; 67(4):185-193. PubMed ID: 28261941 [TBL] [Abstract][Full Text] [Related]
14. [Alzheimer disease: cellular and molecular aspects]. Octave JN Bull Mem Acad R Med Belg; 2005; 160(10-12):445-9; discussion 450-1. PubMed ID: 16768248 [TBL] [Abstract][Full Text] [Related]
15. Early intraneuronal amyloid triggers neuron-derived inflammatory signaling in APP transgenic rats and human brain. Welikovitch LA; Do Carmo S; Maglóczky Z; Malcolm JC; Lőke J; Klein WL; Freund T; Cuello AC Proc Natl Acad Sci U S A; 2020 Mar; 117(12):6844-6854. PubMed ID: 32144141 [TBL] [Abstract][Full Text] [Related]
16. Neuronal clearance of amyloid-β by endocytic receptor LRP1. Kanekiyo T; Cirrito JR; Liu CC; Shinohara M; Li J; Schuler DR; Shinohara M; Holtzman DM; Bu G J Neurosci; 2013 Dec; 33(49):19276-83. PubMed ID: 24305823 [TBL] [Abstract][Full Text] [Related]
17. Effect of Aβ Oligomers on Neuronal APP Triggers a Vicious Cycle Leading to the Propagation of Synaptic Plasticity Alterations to Healthy Neurons. Rolland M; Powell R; Jacquier-Sarlin M; Boisseau S; Reynaud-Dulaurier R; Martinez-Hernandez J; André L; Borel E; Buisson A; Lanté F J Neurosci; 2020 Jul; 40(27):5161-5176. PubMed ID: 32444385 [TBL] [Abstract][Full Text] [Related]
18. β-Amyloid, cholinergic transmission, and cerebrovascular system -- a developmental study in a mouse model of Alzheimer's disease. Kuznetsova E; Schliebs R Curr Pharm Des; 2013; 19(38):6749-65. PubMed ID: 23530514 [TBL] [Abstract][Full Text] [Related]
19. APP transgenic mice Tg2576 accumulate Abeta peptides that are distinct from the chemically modified and insoluble peptides deposited in Alzheimer's disease senile plaques. Kalback W; Watson MD; Kokjohn TA; Kuo YM; Weiss N; Luehrs DC; Lopez J; Brune D; Sisodia SS; Staufenbiel M; Emmerling M; Roher AE Biochemistry; 2002 Jan; 41(3):922-8. PubMed ID: 11790115 [TBL] [Abstract][Full Text] [Related]
20. Diffuse amyloid deposition, but not plaque number, is reduced in amyloid precursor protein/presenilin 1 double-transgenic mice by pathway lesions. van Groen T; Liu L; Ikonen S; Kadish I Neuroscience; 2003; 119(4):1185-97. PubMed ID: 12831872 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]